Etodolac

Product NDC
59651-461
11-digit product format
596510461
Labeler code
59651
Product ID
59651-461_c74c3c56-a5ac-40b4-974b-c4f4b05c5df9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Etodolac
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA214872
Marketing category
ANDA
Marketing start
2026-07-15
Substance
ETODOLAC
Active strength
400 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
unfinished productproduct59651-461UNFINISHEDActive or certified unfinished drug listing2026-10-05
unfinished packagepackage59651-46159651-461-07UNFINISHEDActive or certified unfinished drug listing2026-10-05

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A214872-001ETODOLACETODOLAC400MGTABLET / ORALAB2026-07-15
A214872-002ETODOLACETODOLAC500MGTABLET / ORALAB2026-07-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A214872-001AB
A214872-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A214872-001ETODOLAC400MGTABLET / ORALAB2026-07-1584e616aacf4f…
2026-09-14 22:38:342026-08A214872-002ETODOLAC500MGTABLET / ORALAB2026-07-1584e616aacf4f…
2026-08-18 06:07:402026-07A214872-001ETODOLAC400MGTABLET / ORALAB2026-07-15caaa826d4ba7…
2026-08-18 06:07:402026-07A214872-002ETODOLAC500MGTABLET / ORALAB2026-07-15caaa826d4ba7…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A214872-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A214872-002AB184e616aacf4f…
2026-08-18 06:07:402026-07A214872-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A214872-002AB1caaa826d4ba7…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Etodolac
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ETODOLAC400 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2M36281008Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
197686Internal RxNorm lookup
199390Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
c74c3c56-a5ac-40b4-974b-c4f4b05c5df9Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EtodolacETODOLACAurobindo Pharma Limitedc74c3c56-a5ac-40b4-974b-c4f4b05c5df92026-07-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 214872
application number: ANDA214872
ndc (product): 59651-461

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
59651-461-0159651046101100 TABLET, FILM COATED in 1 BOTTLE (59651-461-01) 2026-07-15NoNoCurrent
59651-461-07596510461071600 TABLET, FILM COATED in 1 BAG (59651-461-07)15-JUL-26Current